Cerebral vasculitis due to Aspergillus spp. in immunocompromised patients: literature review

Int J Infect Dis. 2022 Sep:122:244-251. doi: 10.1016/j.ijid.2022.05.056. Epub 2022 May 28.

Abstract

Objectives: Invasive aspergillosis is a threat for immunocompromised patients. We present a case series of aggressive cerebral vasculitis caused by Aspergillus spp. infection in immunocompromised patients.

Methods: We present a retrospective case series of three autopsy-proven invasive cerebral aspergillosis with diffuse vasculitis affecting large caliber cerebral vessels.

Results: Three patients were immunosuppressed: one on rituximab, one on corticosteroids, and one with a renal transplant. Two of these patients were diagnosed with cerebral aspergillosis on postmortem.

Conclusion: Aspergillus cerebral vasculitis is a rare form of invasive aspergillosis that should be considered in an immunocompromised individual with suggestive lesions on imaging. It should be suspected as a possible cause of aseptic neutrophil meningitis.

Keywords: Aspergillosis; Cerebral infarction; Fungal; Meningitis; Vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Aspergillosis* / diagnosis
  • Aspergillosis* / drug therapy
  • Aspergillus
  • Humans
  • Immunocompromised Host
  • Retrospective Studies
  • Vasculitis, Central Nervous System* / diagnostic imaging
  • Vasculitis, Central Nervous System* / drug therapy